Company logo

PRPO - Precipio, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
New Haven, United States
Type: Equity

PRPO price evolution
PRPO
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $1.28 $0.78 $1.5
Short term investments
Net receivables $1.02 $1.11 $0.91 $1.3
Inventory $0.59 $0.65 $0.53 $0.38
Total current assets $3.25 $3.36 $2.6 $3.68
Long term investments
Property, plant & equipment $1.54 $1.55 $1.38 $1.52
Goodwill & intangible assets $12.34 $12.58 $12.82
Total noncurrent assets $13.95 $14.03 $14.42
Total investments
Total assets $16.95 $17.32 $16.62 $18.1
Current liabilities
Accounts payable $0.7 $0.85 $0.91 $0.62
Deferred revenue $0.26 $0.19 $0.11
Short long term debt $0.56 $0.41 $0.58
Total current liabilities $4.48 $4.59 $3.33 $3.14
Long term debt $0.27 $0.61 $0.52 $0.53
Total noncurrent liabilities $0.61 $0.52 $0.53
Total debt $1.17 $0.93 $1.12
Total liabilities $5.01 $5.2 $3.85 $3.67
Shareholders' equity
Retained earnings -$102.08 -$101.45 -$100.23 -$98.15
Other shareholder equity
Total shareholder equity $12.12 $12.77 $14.43
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $1.5 $3.44 $11.67 $2.66
Short term investments
Net receivables $1.3 $1.04 $0.7 $0.87
Inventory $0.38 $0.71 $0.56 $0.35
Total current assets $3.68 $5.71 $13.48 $4.2
Long term investments
Property, plant & equipment $1.52 $1.9 $2.06 $0.79
Goodwill & intangible assets $12.82 $13.77 $14.72 $15.67
Total noncurrent assets $14.42 $15.79 $16.96 $16.51
Total investments
Total assets $18.1 $21.5 $30.44 $20.71
Current liabilities
Accounts payable $0.62 $2.04 $1.86 $1.69
Deferred revenue $0.11 $0.12 $0.02 $0.01
Short long term debt $0.58 $0.62 $0.41 $0.92
Total current liabilities $3.14 $4.36 $4.21 $4.66
Long term debt $0.53 $0.2 $1.02 $0.57
Total noncurrent liabilities $0.53 $0.78 $1.62 $1.9
Total debt $1.12 $1.39 $1.43 $1.49
Total liabilities $3.67 $5.2 $5.83 $6.55
Shareholders' equity
Retained earnings -$98.15 -$92.3 -$80.09 -$71.56
Other shareholder equity $0.03
Total shareholder equity $14.43 $16.3 $24.56 $14.13
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $5.21 $4.44 $3.43 $4.33
Cost of revenue $2.73 $2.51 $2.32
Gross Profit $2.28 $1.72 $0.92 $2.01
Operating activities
Research & development
Selling, general & administrative $2.92 $2.99 $2.87
Total operating expenses $2.87 $2.92 $2.99 $2.87
Operating income -$1.21 -$2.07 -$0.85
Income from continuing operations
EBIT -$1.21 -$2.07 $0.93
Income tax expense
Interest expense -$0.03 $0.01 $0.01 $0.01
Net income
Net income -$0.63 -$1.22 -$2.08 $0.93
Income (for common shares) -$1.22 -$2.08 $0.93
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $15.2 $9.41 $8.85 $6.09
Cost of revenue $9.18 $6.9 $6.46 $4.94
Gross Profit $6.02 $2.51 $2.39 $1.15
Operating activities
Research & development
Selling, general & administrative $13.64 $15.31 $12.01 $10.3
Total operating expenses $13.64 $15.31 $12.01 $10.3
Operating income -$7.62 -$12.8 -$9.61 -$9.15
Income from continuing operations
EBIT -$5.83 -$12.19 -$8.51 -$10.15
Income tax expense
Interest expense $0.02 $0.01 $0.02 $0.47
Net income
Net income -$5.85 -$12.2 -$8.53 -$10.63
Income (for common shares) -$5.85 -$12.2 -$8.53 -$13.97
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income -$1.22 -$2.08 $0.93
Operating activities
Depreciation $0.37 $0.38 $0.37
Business acquisitions & disposals
Stock-based compensation $0.3 $0.36 $0.39
Total cash flows from operations $0.5 -$0.67 $0.11
Investing activities
Capital expenditures -$0.07 -$0.05
Investments
Total cash flows from investing -$0.18 -$0.07 -$0.05
Financing activities
Dividends paid
Sale and purchase of stock $0.01 $0.07
Net borrowings $0.09 -$0.13 -$0.13
Total cash flows from financing -$0.14 $0.07 -$0.06 -$0.13
Effect of exchange rate
Change in cash and equivalents -$0.45 $0.5 -$0.73 -$0.06
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$5.85 -$12.2 -$8.53 -$10.63
Operating activities
Depreciation $1.52 $1.52 $1.44 $1.36
Business acquisitions & disposals
Stock-based compensation $1.56 $3.8 $1.88 $0.7
Total cash flows from operations -$3.56 -$7.72 -$6.58 -$7.43
Investing activities
Capital expenditures -$0.13 -$0.28 -$0.68 -$0.1
Investments
Total cash flows from investing -$0.13 -$0.28 -$0.68 -$0.1
Financing activities
Dividends paid
Sale and purchase of stock $2.25 $0.14 $16.61 $8.93
Net borrowings -$0.5 -$0.36 -$0.17 $0.41
Total cash flows from financing $1.74 -$0.23 $16.27 $9.34
Effect of exchange rate
Change in cash and equivalents -$1.94 -$8.22 $9.01 $1.81
News
It's Probably Less Likely That Precipio, Inc.'s (NASDAQ:PRPO) CEO Will See A...
Simply Wall St. · via Yahoo Finance 18 Jun 2024
When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?
Simply Wall St. via Yahoo Finance 16 Nov 2023
11 ChatGPT Penny Stock Picks
Insider Monkey via Yahoo Finance 31 Aug 2023
Broker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higher
Simply Wall St. via Yahoo Finance 20 Aug 2023
Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance 19 Aug 2023
8 Best Penny Stocks To Buy Under $1.00
GoBankingRates via AOL 3 Apr 2023
Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance 18 Oct 2022
When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?
Simply Wall St. via Yahoo Finance 11 May 2022
51 Biggest Movers From Yesterday
Benzinga 6 Apr 2022
18 Stocks Moving in Tuesday's Pre-Market Session
Benzinga 5 Apr 2022
Fundamentals
Market cap $8.74M
Enterprise value N/A
Shares outstanding 1.48M
Revenue $17.41M
EBITDA N/A
EBIT N/A
Net Income -$3.00M
Revenue Q/Q 15.29%
Revenue Y/Y 31.31%
P/E ratio -2.91
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 0.50
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS -$2.02
ROA -17.39%
ROE N/A
Debt/Equity 0.25
Net debt/EBITDA N/A
Current ratio 0.73
Quick ratio 0.60